Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
63
GLUE Quote, Financials, Valuation and Earnings
Last price:
$17.64
Seasonality move
:
-9.31%
Day range:
$16.60 - $17.81
52-week range:
$3.50 - $19.17
Dividend yield:
0%
P/E ratio:
57.76x
P/S ratio:
7.51x
P/B ratio:
4.67x
Volume:
482.3K
Avg. volume:
1.1M
1-year change:
150.21%
Market cap:
$1.1B
Revenue:
$75.6M
EPS (TTM):
$0.31
Earnings Data
Next earnings date for GLUE
Mar 19
2026
Most recent earnings per share
-$0.33
Beat by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.35
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GLUE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/19/2026 | Q4 | $15.5M | -- | -- | -$0.32 | -- |
| 11/06/2025 | Q3 | $7.4M | $12.8M | -$0.33 | -$0.35 | $0.02 |
| 08/08/2025 | Q2 | $7.4M | $23.2M | -$0.15 | -$0.36 | $0.21 |
| 05/15/2025 | Q1 | $13.6M | $84.9M | $0.57 | -$0.32 | $0.89 |
| 03/20/2025 | Q4 | $51.2M | $60.6M | $0.22 | $0.03 | $0.19 |
| 11/07/2024 | Q3 | $3.2M | $9.2M | -$0.29 | -$0.47 | $0.18 |
| 08/08/2024 | Q2 | $1.3M | $4.7M | -$0.43 | -$0.54 | $0.12 |
| 05/09/2024 | Q1 | $1.4M | $1.1M | -$0.53 | -$0.58 | $0.05 |
| 03/14/2024 | Q4 | $15.1M | -- | -$0.58 | -$0.39 | -$0.20 |
| 11/09/2023 | Q3 | -- | -- | -$0.70 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.71 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.65 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.63 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.58 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.57 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 02/28/2022 | Q4 | -- | -- | -$0.50 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.43 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.41 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.90 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.15 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.12 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.10 | -- | -- |
Monte Rosa Therapeutics, Inc. Earnings Questions
-
How Much did Monte Rosa Therapeutics, Inc. Generate in Revenue Last Quarter?
Monte Rosa Therapeutics, Inc. reported $12.8M worth of top line sales in its most recent quarter.
-
Did Monte Rosa Therapeutics, Inc. Beat Earnings Last Quarter?
Monte Rosa Therapeutics, Inc. announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.35 per share.
-
Is Monte Rosa Therapeutics, Inc. Profitable?
Monte Rosa Therapeutics, Inc. reported $10.7M that represents $0.13 per share over the last quarter.
-
What is the Analyst Consensus for Monte Rosa Therapeutics, Inc. EPS Next Year?
Monte Rosa Therapeutics, Inc.'s earnings are forecast to decrease from -$0.98 per share to -$1.21 per share next year representing a decrease of -80.01%.
-
When is Monte Rosa Therapeutics, Inc.'s Earnings Date?
Monte Rosa Therapeutics, Inc.'s next earnings date is March 19, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
